Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
In a recent poll, more than one in three Americans reported negative effects of the sequester. That’s up from one in four when the $85 billion in budget cuts took effect in March. A Meals on Wheels Association of America survey showed nearly 70 percent of local programs have had to reduce the number of meals served to housebound seniors. Head Start programs for preschoolers have shrunk, funding for medical research is reduced and national parks are scaling back services. Diane and her guests discuss the broad reach of sequestration on Americans’ lives.
- Jared Bernstein senior fellow at the Center on Budget and Policy Priorities, and former chief economist and economic policy adviser for Vice President Joe Biden.
- Annie Lowrey economic policy reporter for The New York Times.
- Mary Woolley president and CEO at Research!America.
- Vinsen Faris chairman of the board at Meals on Wheels of America.
- Steve Taylor senior vice president of public policy at United Way Worldwide.
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.